Efficacy of debridement in hematogenous and early post-surgical prosthetic joint infections

International Journal of Artificial Organs

Volumn 34, Issue 9, 2011, Pages 863-869

  Vilchez, Félix ^a   Martínez Pastor, Juan C ^a   García Ramiro, Sebastián ^a   Bori, Guillem ^a   Tornero, Eduard ^a   García, Esther ^a   Mensa, Josep ^a   Soriano, Alex ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Debridement; Outcome; Prosthetic joint infection; Staphylococcus aureus

Indexed keywords

FAILURE ANALYSIS; REGRESSION ANALYSIS; SURGERY;

CLINICAL CHARACTERISTICS; CLINICAL OUTCOME; COX'S REGRESSION MODEL; DEBRIDEMENT; OUTCOME; PROSTHETIC JOINT INFECTION; PROSTHETIC JOINTS; S. AUREUS; STUDY CASE; SURGICAL PROSTHETIC;

BACTERIA;

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFTAZIDIME; CLOXACILLIN; LEVOFLOXACIN; RIFAMPICIN; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEBRIDEMENT; DISEASE SEVERITY; FEMALE; FEVER; FOLLOW UP; HIP PROSTHESIS; HUMAN; INFECTIOUS ARTHRITIS; KNEE PROSTHESIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; PROSTHETIC JOINT INFECTION; PROTEIN BLOOD LEVEL; RELAPSE; RETROSPECTIVE STUDY; REVIEW; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT FAILURE;

EID: 81355142844     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000029     Document Type: Review

References (21)

1. Ainscow DA, Denham RA. The risk of haematogenous infection in total joint replacements. J Bone Joint Surg Br. 1984;66(4):580-582.
2. Uckay I, Lubbeke A, Emonet S, et al. Low incidence of haematogenous seeding to total hip and knee prostheses in patients with remote infections. J Infect. 2009;59(5):337-345.
3. Murdoch DR, Roberts SA, Fowler JV, et al. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis. 2001;32(4):647-649.
4. Barberan J. Management of infections of osteoarticular prosthesis. Clin Microbiol Infect. 2006;12 (Suppl 3):93-101.
5. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351(16):1645-1654.
6. Meehan AM, Osmon DR, Duffy MC, Hanssen AD, Keating MR. Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis. 2003;36(7):845-849.
7. Brandt CM, Sistrunk WW, Duffy MC, et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis. 1997;24(5):914-919.
8. Byren I, Bejon P, Atkins BL, et al. One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother. 2009;63(6):1264-1271.
9. Deirmengian C, Greenbaum J, Lotke PA, Booth RE, Lonner JH. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. J Arthroplasty. 2003;18(7 suppl 1):22-26.
10. Marculescu CE, Berbari EF, Hanssen AD, et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis. 2006;42(4):471-478.
11. Morrey BF, Westholm F, Schoifet S, Rand JA, Bryan RS. Longterm results of various treatment options for infected total knee arthroplasty. Clin Orthop Relat Res. 1989;248:120-8.
12. Salgado CD, Dash S, Cantey JR, Marculescu CE. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res. 2007;461:48-53.
13. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am. 1996;78(4):512-23.
14. Betsch BY, Eggli S, Siebenrock KA, Tauber MG, Muhlemann K. Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis. 2008;46(8):1221-1226.
15. Barberan J, Aguilar L, Carroquino G, et al. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med. 2006;119(11):993.e7-10.
16. Choong PF, Dowsey MM, Carr D, Daffy J, Stanley P. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen. Acta Orthop. 2007;78(6):755-765.
17. Laffer RR, Graber P, Ochsner PE, Zimmerli W. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect. 2006;12(5):433-439.
18. Soriano A, Garcia S, Bori G, et al. Treatment of acute postsurgical infection of joint arthroplasty. Clin Microbiol Infect. 2006;12(12):930-933.
19. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA. 1998;279(19):1537-1541.
20. Berdal JE, Skramm I, Mowinckel P, Gulbrandsen P, Bjornholt JV. Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect. 2005;11(10):843-845.
21. John AK, Baldoni D, Haschke M, et al. Efficacy of Daptomycin in Implant-Associated Infection Due to Methicillin- Resistant Staphylococcus aureus: Importance of Combination with Rifampin. Antimicrob Agents Chemother. 2009;53(7):2719-2724.